Corrigendum to “Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19” [Vaccine 64 (2025) 127756]

Vaccine 2026 Open access

Read full text
Authors: Gregório Guilherme Almeida, Jorge Andrade Pinto, Patrícia Machado Pinto, Ludmila Bezerra da Silva, Luis Adan Flores Andrade, Bruno Vinícius Santos Valiate, Nathália Zini, Flávia Fonseca Bagno, Graziella Gomes Rivelli, Karine Lima Lourenço, Jéssica Pauline Coelho Souza, Isabela Pereira Gomes
+16 more Natália Salazar de Castro, Ana Luiza Chaves Maia, Alex Fiorini, Júlio Castro Alves, Júlia Teixeira de Castro, Guangzhao Li, Natália Satchiko Hojo-Souza, Gabriel da Rocha Fernandes, Pedro Augusto Alves, Renata Caldeira Diniz, André Bastos Daher, Renan Pedra Souza, Santuza Maria Ribeiro Teixeira, Ana Paula Salles Moura Fernandes, Ricardo T. Gazzinelli, Helton C. Santiago
DOI: 10.1016/j.vaccine.2026.128316
Cited by: 0

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research vaccines and immunoinformatics approaches Immunotherapy and Immune Responses

Publication details

Journal / source
Vaccine
Volume
76
Pages
128316–128316
Publication date
11 February 2026
Language
EN